The NF-κB pathway is one of the best-characterized signaling pathways in the pathogenesis of a wide variety of diseases, including liver diseases like NAFLD, inflammatory disorders, and tumor development [31,32]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.